Published March 2015 | Version v1
Journal article

Coronary calcium score in 12-year breast cancer survivors after adjuvant radiotherapy with low to moderate heart exposure – Relationship to cardiac radiation dose and cardiovascular risk factors

  • 1. National Advisory Unit on Late Effects After Cancer Treatment, Oslo University Hospital, Department of Clinical Cancer Research (Norway)
  • 2. Department of Radiology and Nuclear Medicine, Division of Diagnostics and Intervention, Oslo University Hospital (Norway)
  • 3. Department of Oncology, Oslo University Hospital, Oslo and Akershus University College of Applied Sciences, Faculty of Health Sciences (Norway)

Description

Background/purpose: We explored the relation between coronary artery calcium (CAC) and cardiac radiation doses in breast cancer survivors (BCS) treated with radiotherapy (RT). Additionally, we examined the impact of other risk factors and biomarkers of coronary artery disease (CAD). Materials and methods: 236 BCS (median age 51 years [range 30–70], median observation time 12 years [9.2–15.7]), treated with 4-field RT of 50GY, were included and examined in 2004 (T1), 2007 (T2) and 2011 (T3) with clinical examination, blood tests and questionnaires. At T3, cardiac computed tomography was performed with quantification of CAC using Agatston score (AS). For 106 patients cardiac dose volume histograms were available. Results: The cohort-based median of the mean cardiac dose was 2.5 (range 0.5–7.0) Gy. There was no correlation between measures of cardiac dose and AS. AS was correlated with high cholesterol at T1/T2 (p = 0.022), high proBNP at T1/T2 (p < 0.022) and T3 (p < 0.022) and high HbA1c at T3 (p = 0.022). In addition, a high AS was significantly associated with hypertension (p = 0.022). Age (p < 0.001) and cholesterol at T1/T2 (p = 0.001) retained significant associations in multivariate analysis. Conclusions: Traditional, modifiable risk factors of CAD correlate with CAC and may be important for the long term risk of CAD after RT. With low to moderate cardiac radiation exposure, a contribution of radiation dose to CAC could not be demonstrated

Availability note (English)

Available from http://dx.doi.org/10.1016/j.radonc.2015.01.006

Additional details

Identifiers

DOI
10.1016/j.radonc.2015.01.006;
PII
S0167-8140(15)00032-8;

Publishing Information

Journal Title
Radiotherapy and Oncology
Journal Volume
114
Journal Issue
3
Journal Page Range
p. 328-334
ISSN
0167-8140
CODEN
RAONDT

Optional Information

Copyright
Copyright (c) 2015 Elsevier Science B.V., Amsterdam, The Netherlands, All rights reserved.